MedPath

Comparison of the Efficacy and Safety of two treatment modalities for Pitted Keratolysis with Five Percent Benzoyl Peroxide Versus Fusidic Acid

Not Applicable
Conditions
Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Registration Number
CTRI/2024/08/072543
Lead Sponsor
Dr Namrata Sandeep Kenkre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Newly diagnosed pitted keratolysis

Exclusion Criteria

1.Patients on antiperspirants ( such as aluminium chloride, aluminium zirconium and aluminium chlorohydrate)

2.Patients with hypersensitivity to drugs (topical fusidic acid and benzoyl peroxide)

3.Patients on topical sulfone products (e.g., dapsone)

4.Patients on topical hydroquinone.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath